Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...
SAN FRANCISCO — The first prospective international randomized controlled study focusing specifically on angina in patients with diabetes has shown that ranolazine (Ranexa, Gilead Sciences) is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results